Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Neurotrophic Keratitis > Study links corneal nerve loss, immune activation, and stem cell deficiency in neurotrophic keratitis
  • Neurotrophic Keratitis

Study links corneal nerve loss, immune activation, and stem cell deficiency in neurotrophic keratitis

Ophthalmology 360

Key Takeaways

  1. Neurotrophic keratitis shows combined corneal nerve loss, stem cell deficiency, and immune activation.
  2. Nerve, stem cell, immune, and staining changes are significantly linked.
  3. Recombinant human nerve growth factor treatment shows early surface improvement followed by nerve recovery.

Neurotrophic keratitis (NK) is associated with linked damage to corneal nerves, limbal epithelial stem cells (LESCs), and immune activation, according to a study.

The study included 54 patients with neurotrophic keratitis (55 eyes) and 57 healthy controls (59 eyes). In vivo confocal microscopy (IVCM) was used to assess subbasal corneal nerve fiber density (CNFD), corneal nerve fiber length (CNFL), corneal nerve branch density (CNBD), limbal epithelial basal cell (LEBC) density in multiple directions, and dendritic cell (DC) status. In a subgroup treated with recombinant human nerve growth factor (rhNGF) (7 eyes of 7 patients), measurements were recorded at baseline, weeks 4 and 8, and at a 2-year follow-up.

Key findings compared with healthy controls:

  • CNFD, CNFL, and CNBD were significantly lower in patients with NK (all P < 0.01).
  • Central basal cell density and peripheral LESC density were markedly reduced (both P < 0.001).
  • DC density and DC activation ratio were significantly higher in the NK group (both P < 0.001).

Key correlations in the NK group:

  • CNFD was positively correlated with LESC density (P = 0.46; P < 0.001).
  • CNFD was negatively correlated with fluorescein staining scores (P = −0.46; P < 0.001).
  • CNFD was negatively correlated with DC density (P = −0.57; P < 0.001).
  • LESC density was negatively correlated with fluorescein staining scores (P = −0.62; P < 0.001).
  • LESC density was negatively correlated with mean DC area (P = −0.44; P < 0.001).
  • Fluorescein staining scores were positively correlated with DC density (P = 0.44; P < 0.001).

In the rhNGF-treated subgroup, improvements in LESC density, DC density, DC activation, and fluorescein staining scores were observed by week 4. Nerve regeneration became detectable after 8 weeks and showed significant recovery by the 2-year follow-up.

Reference

Yan Y, Yang Z, Deng Q, Cheng S, Wan S, Pan J, Huang L, Yang Y. Association between Neurotrophic Keratitis and Limbal Stem Cell Deficiency. Am J Ophthalmol. 2026;S0002-9394(26)00029-2. doi: 10.1016/j.ajo.2026.01.021. Epub ahead of print. PMID: 41617121.

Share

Related Content

  • Neurotrophic Keratitis

Cenegermin improves corneal healing in moderate to severe neurotrophic keratitis

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Neurotrophic Keratitis

Early detection and targeted treatment strategies are critical for optimal outcomes in neurotrophic keratitis

  • Neurotrophic Keratitis

Amniotic membrane improves severe autoimmune-related KCS and NK outcomes

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon